Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
株式のランク #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
株価
$59.98
最終同期: 2024-12-13
時価総額
$1.22B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Longboard Pharmaceuticals, Inc. (LBPH)

カテゴリー

Longboard Pharmaceuticals, Inc.(LBPH)のEPS
September 2024 時点のEPS TTM: $-2.24
Longboard Pharmaceuticals, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-2.24です。2022年末には、EPSは$-2.51で、2021年のEPS$-1.62と増加でした。
Longboard Pharmaceuticals, Inc.のEPS履歴(2020から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -873.21%
US
$27.74 -1,338.39%
NL
$-5.29 136.16%
AU
$-7.98 256.25%
US
- -
CH